It is also worth noting that genome-wide association studies (GWAS) from patients with immune-mediated diseases including RA revealed single-nucleotide polymorphisms in IPMK, suggesting IPMK as a candidate risk factor for RA (Yokoyama et al. 2016). Here, IPMK is linked to rheumatoid arthritis.